{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T19:31:16Z","timestamp":1781292676833,"version":"3.54.1"},"reference-count":91,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/aci.0b013e3282f824a4","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T15:54:51Z","timestamp":1236268491000},"page":"126-134","source":"Crossref","is-referenced-by-count":39,"title":["Immunology of chronic beryllium disease"],"prefix":"10.1097","volume":"8","author":[{"given":"George","family":"Samuel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210203","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00043764-199904000-00013","article-title":"Beryllium copper alloy (2%) causes chronic beryllium disease","volume":"41","author":"Balkissoon","year":"1999","journal-title":"J Occup Environ Med"},{"key":"R3-6-20210203","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1080\/15459620490502233","article-title":"Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed","volume":"1","author":"Henneberger","year":"2004","journal-title":"J Occup Environ Hyg"},{"key":"R4-6-20210203","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(04)15523-2","article-title":"Beryllium exposure and chronic beryllium disease","volume":"363","author":"Infante","year":"2004","journal-title":"Lancet"},{"key":"R5-6-20210203","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/ajrccm\/148.4_Pt_1.985","article-title":"Epidemiology of beryllium sensitization and disease in nuclear workers","volume":"148","author":"Kreiss","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"R6-6-20210203","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1097-0274(199607)30:1<16::AID-AJIM3>3.0.CO;2-Q","article-title":"Machining risk of beryllium disease and sensitization with median exposures below 2 \u03bcg\/m3","volume":"30","author":"Kreiss","year":"1996","journal-title":"Am J Industr Med"},{"key":"R7-6-20210203","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00043764-200103000-00012","article-title":"Beryllium particulate exposure and disease relations in a beryllium machining plant","volume":"43","author":"Kelleher","year":"2001","journal-title":"J Occup Environ Med"},{"key":"R8-6-20210203","first-page":"267","article-title":"Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations","volume":"35","author":"Kreiss","year":"1993","journal-title":"J Occup Med"},{"key":"R9-6-20210203","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ajim.20059","article-title":"Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites","volume":"46","author":"Welch","year":"2004","journal-title":"Am J Ind Med"},{"key":"R10-6-20210203","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.jom.0000139872.80118.bd","article-title":"Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations","volume":"46","author":"Sackett","year":"2004","journal-title":"J Occup Environ Med"},{"key":"R11-6-20210203","first-page":"937","article-title":"The natural history of beryllium sensitization and chronic beryllium disease","volume":"104","author":"Newman","year":"1996","journal-title":"Environ Health Perspect"},{"key":"R12-6-20210203","first-page":"953","article-title":"Significance of the blood beryllium lymphocyte proliferation test","volume":"104","author":"Newman","year":"1996","journal-title":"Environ Health Perspect"},{"key":"R13-6-20210203","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1378\/chest.109.3_Supplement.40S","article-title":"Immunology, genetics, and epidemiology of beryllium disease","volume":"109","author":"Newman","year":"1996","journal-title":"Chest"},{"key":"R14-6-20210203","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-108-5-687","article-title":"Proliferative response of bronchoalveolar lymphocytes to beryllium: A test for chronic beryllium disease","volume":"108","author":"Rossman","year":"1988","journal-title":"Ann Intern Med"},{"key":"R15-6-20210203","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00043764-198907000-00011","article-title":"Screening blood test identifies subclinical beryllium disease","volume":"31","author":"Kreiss","year":"1989","journal-title":"J Occup Med"},{"key":"R16-6-20210203","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0091-6749(91)90300-D","article-title":"Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease","volume":"88","author":"Mroz","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"R17-6-20210203","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJM198904273201702","article-title":"Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells","volume":"320","author":"Saltini","year":"1989","journal-title":"N Engl J Med"},{"key":"R18-6-20210203","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.4049\/jimmunol.171.12.6910","article-title":"Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease","volume":"171","author":"Maier","year":"2003","journal-title":"J Immunol"},{"key":"R19-6-20210203","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/aje\/kwg001","article-title":"HLA-DPB1 and chronic beryllium disease: a HuGE review","volume":"157","author":"McCanlies","year":"2003","journal-title":"Am J Epidemiol"},{"key":"R20-6-20210203","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/ajrccm.165.6.2104002","article-title":"Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity","volume":"165","author":"Rossman","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"R21-6-20210203","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4049\/jimmunol.163.3.1647","article-title":"Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles","volume":"163","author":"Wang","year":"1999","journal-title":"J Immunol"},{"key":"R22-6-20210203","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0300-483X(01)00410-3","article-title":"Beryllium sensitivity is linked to HLA-DP genotype","volume":"165","author":"Wang","year":"2001","journal-title":"Toxicology"},{"key":"R23-6-20210203","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0022-3565(24)39216-X","article-title":"Effects of cigarette smoke on immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP3-sensitive Ca(2+) stores","volume":"293","author":"Kalra","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"R24-6-20210203","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1172\/JCI24908","article-title":"Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response","volume":"115","author":"Fontenot","year":"2005","journal-title":"J Clin Invest"},{"key":"R25-6-20210203","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.200402-190OC","article-title":"Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk","volume":"171","author":"Newman","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R26-6-20210203","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2005.01.019","article-title":"Frequency of beryllium-specific, TH1-type cytokine-expressing CD4+ T cells in patients with beryllium-induced disease","volume":"115","author":"Pott","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"R27-6-20210203","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/ajim.10227","article-title":"Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease","volume":"43","author":"Maier","year":"2003","journal-title":"Am J Ind Med"},{"key":"R28-6-20210203","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1164\/ajrccm\/137.2.464","article-title":"The pulmonary toxicity of beryllium","volume":"137","author":"Kriebel","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"R29-6-20210203","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1164\/ajrccm\/139.6.1479","article-title":"Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history","volume":"139","author":"Newman","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"R30-6-20210203","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/01.jom.0000184884.85325.36","article-title":"Secondary ion mass spectroscopy demonstrates retention of beryllium in chronic beryllium disease granulomas","volume":"47","author":"Sawyer","year":"2005","journal-title":"J Occup Environ Med"},{"key":"R31-6-20210203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0046-8177(70)80003-X","article-title":"Beryllium disease: The relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the U.S. Beryllium Case Registry","volume":"1","author":"Freiman","year":"1970","journal-title":"Hum Pathol"},{"key":"R33-6-20210203","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1056\/NEJM196511252732205","article-title":"Beryllium poisoning: Lessons in control of man-made disease","volume":"273","author":"Hardy","year":"1965","journal-title":"N Engl J Med"},{"key":"R36-6-20210203","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1148\/radiology.163.3.3575713","article-title":"Chronic beryllium disease: Diagnosis, radiographic findings, and correlation with pulmonary function tests","volume":"163","author":"Aronchick","year":"1987","journal-title":"Radiology"},{"key":"R37-6-20210203","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1148\/50.6.770","article-title":"Delayed chemical pneumonitis or diffuse granulomatosis of the lung due to beryllium","volume":"50","author":"Wilson","year":"1948","journal-title":"Radiology"},{"key":"R38-6-20210203","first-page":"467","article-title":"A consideration of the roentgen diagnosis of chronic pulmonary granulomatosis of beryllium workers","volume":"63","author":"Robert","year":"1950","journal-title":"AJR"},{"key":"R39-6-20210203","first-page":"879","article-title":"Roentgenologic patterns in long-standing beryllium disease: Report of eight cases","volume":"93","author":"Weber","year":"1965","journal-title":"AJR"},{"key":"R40-6-20210203","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1148\/radiology.190.3.8115636","article-title":"Beryllium disease: Assessment with CT","volume":"190","author":"Newman","year":"1994","journal-title":"Radiology"},{"key":"R41-6-20210203","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0009-9260(05)81209-7","article-title":"The computed tomographic appearances in chronic berylliosis","volume":"47","author":"Harris","year":"1993","journal-title":"Clin Radiol"},{"key":"R42-6-20210203","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0033-8389(03)00108-8","article-title":"High-resolution CT in the evaluation of occupational and environmental disease","volume":"40","author":"Akira","year":"2002","journal-title":"Radiol Clin North Am"},{"key":"R43-6-20210203","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00004728-200307000-00007","article-title":"Ground-glass computed tomography pattern in chronic beryllium disease: pathologic substratum and evolution","volume":"27","author":"Naccache","year":"2003","journal-title":"J Comput Assist Tomogr"},{"key":"R44-6-20210203","first-page":"791","article-title":"Patterns of lung dysfunction in chronic beryllium disease","volume":"100","author":"Andrews","year":"1969","journal-title":"Am Rev Respir Dis"},{"key":"R45-6-20210203","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/ajrccm\/148.3.661","article-title":"Early pulmonary physiologic abnormalities in beryllium disease","volume":"148","author":"Pappas","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"R46-6-20210203","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0002-9343(69)90074-6","article-title":"Chronic beryllium disease: Long-term follow-up of sixty cases and selective review of the literature","volume":"46","author":"Stoeckle","year":"1969","journal-title":"Am J Med"},{"key":"R47-6-20210203","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1378\/chest.120.5.1702","article-title":"Indirect and direct gas exchange at maximum exercise in beryllium sensitization and disease","volume":"120","author":"Lundgren","year":"2001","journal-title":"Chest"},{"key":"R48-6-20210203","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1183\/09031936.01.00106201","article-title":"Major histocompatibility locus genetic markers of beryllium sensitization and disease","volume":"18","author":"Saltini","year":"2001","journal-title":"Eur Respir J"},{"key":"R49-6-20210203","doi-asserted-by":"crossref","first-page":"12717","DOI":"10.1073\/pnas.220430797","article-title":"Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease","volume":"97","author":"Fontenot","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"R50-6-20210203","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0162-0134(02)00628-1","article-title":"Potential binding modes of beryllium with the class II major histocompatibility complex HLA-DP: a combined theoretical and structural database study","volume":"94","author":"Scott","year":"2003","journal-title":"J Inorg Biochem"},{"key":"R51-6-20210203","first-page":"1098","article-title":"Impact of negatively charged patches of the surface of ARHC class II antigen-presenting proteins on risk of chronic beryllium disease","volume":"10","author":"Snyder","year":"2007","journal-title":"Journal of Royal Society Interface"},{"key":"R52-6-20210203","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.4049\/jimmunol.177.6.3874","article-title":"Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T cells","volume":"177","author":"Fontenot","year":"2006","journal-title":"J Immunol"},{"key":"R53-6-20210203","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.clim.2006.03.012","article-title":"T cell recognition in chronic beryllium disease","volume":"121","author":"Amicosante","year":"2006","journal-title":"Clin Immunol"},{"key":"R54-6-20210203","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4049\/jimmunol.163.2.1019","article-title":"Identification of pathogenic T cells in patients with beryllium-induced lung disease","volume":"163","author":"Fontenot","year":"1999","journal-title":"J Immunol"},{"key":"R55-6-20210203","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1165\/ajrcmb.18.4.2981","article-title":"Expansions of T cell subsets expressing particular T cell receptor variable regions in chronic beryllium disease","volume":"18","author":"Fontenot","year":"1998","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R56-6-20210203","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.4049\/jimmunol.163.2.1019","article-title":"Identification of pathogenic T cells in patients with beryllium-induced lung disease","volume":"163","author":"Fontenot","year":"1999","journal-title":"J Immunol"},{"key":"R57-6-20210203","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.4049\/jimmunol.166.5.3549","article-title":"HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease","volume":"166","author":"Lombardi","year":"2001","journal-title":"J Immunol"},{"key":"R58-6-20210203","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/clim.2001.5053","article-title":"Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP","volume":"100","author":"Fontenot","year":"2001","journal-title":"Clin Immunol"},{"key":"R59-6-20210203","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.8105536","article-title":"HLA-DPB1 glutamate 69: a genetic marker of beryllium disease","volume":"262","author":"Richeldi","year":"1993","journal-title":"Science"},{"key":"R60-6-20210203","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-0274(199710)32:4<337::AID-AJIM3>3.0.CO;2-R","article-title":"Interaction of genetic and exposure factors in the prevalence of berylliosis","volume":"32","author":"Richeldi","year":"1997","journal-title":"Am J Ind Med"},{"key":"R61-6-20210203","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajim.20045","article-title":"The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization","volume":"46","author":"McCanlies","year":"2004","journal-title":"Am J Ind Med"},{"key":"R62-6-20210203","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1465-9921-6-94","article-title":"Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69","volume":"6","author":"Amicosante","year":"2005","journal-title":"Respir Res"},{"key":"R63-6-20210203","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mrfmmm.2005.06.005","article-title":"Immunogenetic factors in beryllium sensitization and chronic beryllium disease","volume":"592","author":"Weston","year":"2005","journal-title":"Mutat Res"},{"key":"R64-6-20210203","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.4049\/jimmunol.169.12.6928","article-title":"HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity","volume":"169","author":"Castelli","year":"2002","journal-title":"J Immunol"},{"key":"R65-6-20210203","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/intimm\/dxg057","article-title":"Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84\u201387 in T cell allorecognition and peptide binding","volume":"15","author":"Diaz","year":"2003","journal-title":"Int Immunol"},{"key":"R66-6-20210203","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1399-0039.2003.00131.x","article-title":"Detailed analysis of the effects of Glu\/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity","volume":"62","author":"Berretta","year":"2003","journal-title":"Tissue Antigens"},{"key":"R67-6-20210203","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1399-0039.2003.00160.x","article-title":"Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity","volume":"62","author":"Fontenot","year":"2003","journal-title":"Tissue Antigens"},{"key":"R68-6-20210203","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.it.2005.08.004","article-title":"Genetic susceptibility and immune-mediated destruction in beryllium-induced disease","volume":"26","author":"Fontenot","year":"2005","journal-title":"Trends Immunol"},{"key":"R69-6-20210203","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.4049\/jimmunol.175.10.7029","article-title":"Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II \u03b2-Chain","volume":"175","author":"Bill","year":"2005","journal-title":"J Immunol"},{"key":"R70-6-20210203","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI0215846","article-title":"Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease","volume":"110","author":"Fontenot","year":"2002","journal-title":"J Clin Invest"},{"key":"R71-6-20210203","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1183\/09031936.02.02232001","article-title":"HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells","volume":"20","author":"Amicosante","year":"2002","journal-title":"Eur Respir J"},{"key":"R72-6-20210203","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1165\/rcmb.2003-0336OC","article-title":"Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP","volume":"31","author":"Sawyer","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R73-6-20210203","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1084\/jem.171.4.1123","article-title":"Biased accumulation of T lymphocytes with \u201cmemory\u201d-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung","volume":"171","author":"Saltini","year":"1990","journal-title":"J Exp Med"},{"key":"R74-6-20210203","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.168.7.3627","article-title":"Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung","volume":"168","author":"Fontenot","year":"2002","journal-title":"J Immunol"},{"key":"R75-6-20210203","first-page":"747","article-title":"Current concepts of the pathogenesis of sarcoidosis: State of art","volume":"135","author":"Thomas","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"R76-6-20210203","first-page":"197","article-title":"Delayed chemical pneumonitis in workers exposed to beryllium compounds","volume":"28","author":"Hardy","year":"1946","journal-title":"J Industr Hyg Toxicol"},{"key":"R77-6-20210203","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1165\/ajrcmb.10.5.8179912","article-title":"Alveolar macrophages from patients with beryllium disease and sarcoidosis express mRNA for TNF-\u03b1 and IL-6 but not IL-1\u03b2","volume":"10","author":"Bost","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R78-6-20210203","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4049\/jimmunol.158.1.518","article-title":"Beryllium induces IL-2 and IFN-gamma in berylliosis","volume":"158","author":"Tinkle","year":"1997","journal-title":"J Immunol"},{"key":"R79-6-20210203","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1183\/09031936.98.12061463","article-title":"Immunogenetic basis of environmental lung disease: lessons from the berylliosis model","volume":"12","author":"Saltini","year":"1998","journal-title":"Eur Respir J"},{"key":"R80-6-20210203","first-page":"517","article-title":"Tumor Necrosis Factor","author":"Zhang","year":"1998"},{"key":"R81-6-20210203","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1164\/ajrccm.164.7.2012123","article-title":"High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease","volume":"164","author":"Maier","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R82-6-20210203","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nri727","article-title":"The B7-CD28 superfamily","volume":"2","author":"Sharpe","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R83-6-20210203","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/1074-7613(95)90000-4","article-title":"New perspectives of CD28-B7-mediated T cell costimulation","volume":"2","author":"Bluestone","year":"1995","journal-title":"Immunity"},{"key":"R84-6-20210203","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/356607a0","article-title":"CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones","volume":"356","author":"Harding","year":"1992","journal-title":"Nature"},{"key":"R85-6-20210203","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.2113314","article-title":"A cell culture model for T lymphocyte clonal anergy","volume":"248","author":"Schwartz","year":"1990","journal-title":"Science"},{"key":"R86-6-20210203","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.4049\/jimmunol.152.6.2675","article-title":"Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells","volume":"152","author":"Croft","year":"1994","journal-title":"J Immunol"},{"key":"R87-6-20210203","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1172\/JCI200318317","article-title":"CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells","volume":"112","author":"Fontenot","year":"2003","journal-title":"J Clin Invest"},{"key":"R88-6-20210203","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.4049\/jimmunol.163.5.2747","article-title":"Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease","volume":"163","author":"Tinkle","year":"1999","journal-title":"J Immunol"},{"key":"R89-6-20210203","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.4049\/jimmunol.179.6.4255","article-title":"TGF-beta1 variants in chronic beryllium disease and sarcoidosis","volume":"179","author":"Jonth","year":"2007","journal-title":"J Immunol"},{"key":"R90-6-20210203","first-page":"29","article-title":"Analysis of TNF-alpha promoter polymorphisms in the susceptibility to beryllium hypersensitivity","volume":"21","author":"Dotti","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R91-6-20210203","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00109-004-0626-0","article-title":"Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease","volume":"83","author":"Gaede","year":"2005","journal-title":"J Mol Med"},{"key":"R92-6-20210203","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/JOM.0b013e31803b9499","article-title":"TNF-alpha polymorphisms in chronic beryllium disease and beryllium sensitization","volume":"49","author":"McCanlies","year":"2007","journal-title":"J Occup Environ Med"},{"key":"R93-6-20210203","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jaci.2006.10.028","article-title":"TNF polymorphism and bronchoalveolar lavage cell TNF-\u03b1 levels in chronic beryllium disease and beryllium sensitization","volume":"119","author":"Sato","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R94-6-20210203","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.4049\/jimmunol.176.12.7354","article-title":"BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation","volume":"176","author":"Nguyen","year":"2006","journal-title":"J Immunol"},{"key":"R95-6-20210203","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1399-0039.2007.00944.x","article-title":"BTNL2 allele associations with chronic beryllium disease in HLA-DPB1 *Glu69-negative individuals","volume":"70","author":"Sato","year":"2007","journal-title":"Tissue Antigens"}],"container-title":["Current Opinion in Allergy &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0b013e3282f824a4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T01:29:32Z","timestamp":1738978172000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130832-200804000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e3282f824a4","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}